1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 10-16, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: May 10-16, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

No Significant Event

Official Name: Sean R. Keveney, J.D., Chief Counsel

Event Date: 05/11/2026
Location: Washington, DC
Subject: Active Ingredient of BOTOX 
FDA Participant/Group: N/A
Non FDA Participant/Group: Dan Bachner, Johanna Corbin, Trang Lin (AbbVie);

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 05/12/2026
Location: Washington, DC
Subject: Vistria Policy Network Convening; Panelist: Fireside Chat Panel
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, and other stakeholders

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Foods

Event Date: 05/12/2026
Location: Washington, DC
Subject: Produce Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Western Growers Board of Directors

Official Name: Melanie Keller, M.B.A., Deputy Commissioner for Operations and Chief Operating Officer

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

Event Date: 05/11/2026
Location: Virtual
Subject: National Association of State Departments of Agriculture (NASDA) / FDA Quarterly Check-In Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: National Association of State Departments of Agriculture (NASDA) representatives

Official Name: Katherine Szarama, Ph.D., Acting Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 05/11/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates 
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Apple representatives

Event Date: 05/11/2026
Location: Virtual
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: AbbVie representatives

Event Date: 05/11/2026
Location: Virtual
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Medtronic representatives

Event Date: 05/11/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Formation Bio representatives

Event Date: 05/12/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Philips representatives

Official Name: Tracy Beth Høeg M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine

Event Date: 05/15/2026
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Animal Health Institute (AHI) representatives

Back to Top